SNX

171.99

+0.84%↑

PII

68.8

-0.33%↓

SNX

171.99

+0.84%↑

PII

68.8

-0.33%↓

SNX

171.99

+0.84%↑

PII

68.8

-0.33%↓

SNX

171.99

+0.84%↑

PII

68.8

-0.33%↓

SNX

171.99

+0.84%↑

PII

68.8

-0.33%↓

Search

Diversified Healthcare Trust

Closed

SectorIndices

6.32 -0.32

Overview

Share price change

24h

Current

Min

6.26

Max

6.49

Key metrics

By Trading Economics

Income

-72M

-164M

Sales

6M

389M

Dividend yield

0.69

Profit margin

-42.202

EBITDA

-113M

-54M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-9.73% downside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.69%

6.48%

Next Earnings

23 Feb 2026

Next Dividend date

19 Feb 2026

Next Ex Dividend date

21 Apr 2026

Market Stats

By TradingEconomics

Market Cap

347M

1.4B

Previous open

6.64

Previous close

6.32

Technical Score

By Trading Central

Confidence

Bullish Evidence

Diversified Healthcare Trust Chart

Past performance is not a reliable indicator of future results.

Related News

9 Feb 2026, 17:25 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9 Feb 2026, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9 Feb 2026, 23:43 UTC

Market Talk

Gold Falls on Possible Technical Correction -- Market Talk

9 Feb 2026, 23:14 UTC

Market Talk

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9 Feb 2026, 22:29 UTC

Market Talk

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9 Feb 2026, 22:19 UTC

Market Talk

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9 Feb 2026, 22:08 UTC

Market Talk

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9 Feb 2026, 22:01 UTC

Earnings

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9 Feb 2026, 21:59 UTC

Earnings

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9 Feb 2026, 21:59 UTC

Earnings

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9 Feb 2026, 21:58 UTC

Earnings

Friedman Industries 3Q Sales $168M >FRD

9 Feb 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

9 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 Feb 2026, 21:48 UTC

Earnings

Friedman Industries 3Q EPS 43c >FRD

9 Feb 2026, 21:17 UTC

Earnings

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9 Feb 2026, 21:13 UTC

Market Talk

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9 Feb 2026, 21:04 UTC

Earnings

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9 Feb 2026, 20:30 UTC

Market Talk

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9 Feb 2026, 20:02 UTC

Market Talk

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9 Feb 2026, 19:42 UTC

Market Talk

Japan's Yield Curve Expected to Flatten -- Market Talk

9 Feb 2026, 19:31 UTC

Market Talk

Nike Seen Regaining Relevance With Consumers -- Market Talk

9 Feb 2026, 19:27 UTC

Market Talk

Gold Climbs Back Over $5,000/oz -- Market Talk

9 Feb 2026, 19:05 UTC

Market Talk

Nike Returns to List of Hottest Brands -- Market Talk

9 Feb 2026, 18:19 UTC

Market Talk

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9 Feb 2026, 17:41 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 Feb 2026, 17:31 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 Feb 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

9 Feb 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 Feb 2026, 17:17 UTC

Market Talk

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9 Feb 2026, 17:16 UTC

Earnings

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Peer Comparison

Price change

Diversified Healthcare Trust Forecast

Price Target

By TipRanks

-9.73% downside

12 Months Forecast

Average 5.75 USD  -9.73%

High 6.5 USD

Low 5 USD

Based on 2 Wall Street analysts offering 12 month price targets forDiversified Healthcare Trust - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

2.34 / 3.02Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Neutral Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Diversified Healthcare Trust

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.
help-icon Live chat